drugset

drugset / Trial / NCT02648919

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

NCT02648919 ↗

Phase 2 Terminated 6 enrolled University of Hawaii University of Hawaii Cancer Research Center · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of Noni extract in men diagnosed with very low risk or low risk prostate cancer

Timeline

Start: 2015-12
Primary completion: 2018-12
Completion: 2018-12

Outcome

Outcome not reported

Stopped (Enrollment): “low accrual”

Publications

Background Issell BF, Franke A, Fielding RM. Pharmacokinetic study of Noni fruit extract. J Diet Suppl. 2008;5(4):373-82. doi: 10.1080/19390210802519671.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Noni extract	Unknown	6000 mg	—

Indications